Early detection of Alzheimer's disease using MRI hippocampal texture

Human Brain Mapping

Volumn 37, Issue 3, 2016, Pages 1148-1161

  Sørensen, Lauge ^a,b   Igel, Christian ^a   Liv Hansen, Naja ^a,c   Osler, Merete ^a,c   Lauritzen, Martin ^a,c   Rostrup, Egill ^a,c   Nielsen, Mads ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BiomedIQ A/S   (Denmark)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Biomarker; Classification; Early diagnosis; Hippocampus; Image analysis; Machine learning; Magnetic resonance imaging; Mild cognitive impairment

Indexed keywords

FLUORODEOXYGLUCOSE; GLUCOSE;

AGED; ALZHEIMER DISEASE; ANTHROPOMETRIC PARAMETERS; AREA UNDER THE MOMENT CURVE; ARTICLE; ASSOCIATION; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPAL TEXTURE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; VOLUMETRY; AREA UNDER THE CURVE; COGNITION; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FACTUAL DATABASE; METABOLISM; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROCEDURES;

AGED; ALZHEIMER DISEASE; AREA UNDER CURVE; COGNITION; COHORT STUDIES; DATABASES, FACTUAL; EARLY DIAGNOSIS; FEMALE; GLUCOSE; HIPPOCAMPUS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS;

EID: 84958292005     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.23091     Document Type: Article

References (57)

1. Achterberg HC, van der Lijn F, den Heijer T, Vernooij MW, Ikram MA, Niessen WJ, de Bruijne M (2014): Hippocampal shape is predictive for the development of dementia in a normal, elderly population. Hum Brain Mapp 35:2359-2371.
2. Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, Rusinek H, Wisniewski HM (2000): The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 95:721-725.
3. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, Mlodzik B, de Leon MJ, Miller DC (1995): Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia 6:205-210.
4. Bron EE, Smits M, van der Flier WM, Vrenken H, Barkhof F, Scheltens P, Papma JM, Steketee RM, Mendez Orellana C, Meijboom R, Pinto M, Meireles JR, Garrett C, Bastos-Leite AJ, Abdulkadir A, Ronneberger O, Amoroso N, Bellotti R, Cárdenas-Peña D, Álvarez-Meza AM, Dolph CV, Iftekharuddin KM, Eskildsen SF, Coupé P, Fonov VS, Franke K, Gaser C, Ledig C, Guerrero R, Tong T, Gray KR, Moradi E, Tohka J, Routier A, Durrleman S, Sarica A, Di Fatta G, Sensi F, Chincarini A, Smith GM, Stoyanov ZV, Sørensen L, Nielsen M, Tangaro S, Inglese P, Wachinger C, Reuter M, van Swieten JC, Niessen WJ, Klein S, for The Alzheimer's Disease Neuroimaging Initiative (2015): Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge. Neuroimage 111:562-579.
5. Braak H, Braak E (1997): Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357.
6. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ (2004): A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 23:724-738.
7. Castellano G, Bonilha L, Li LM, Cendes F (2004): Texture analysis of medical images. Clin Radiol 59:1061-1069.
8. Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, and others. (2011): Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage 58:469-480.
9. Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, George A (1997): Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 18:131-138.
10. Cortes C, Mohri M (2004): AUC optimization vs. error rate minimization. Nips 313-320.
11. Cortes C, Vapnik V (1995): Support-vector networks. Mach Learn 20:273-297.
12. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu C-Y, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, et al. (2011): Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56:212-219.
13. Cummings J, Zhong K (2014): Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations. Clin Pharmacol Ther 95:67-77.
14. DeLong ER, DeLong DM, Clarke-Pearson DL (1988): Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
15. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, et al. (2007): Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68:828-836.
16. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, et al. (2010): Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 9:1118-1127.
17. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, et al. (2009): The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21:672-687.
18. Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D, Group A (2010): Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement 6:291-296.
19. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, et al. (2002): Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341-355.
20. Fox NC, Freeborough PA (1997): Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging 7:1069-1075.
21. Freeborough PA, Fox NC (1998): MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease. IEEE Trans Med Imaging 17:475-479.
22. Frisoni GB, Fox NC, Jack J, Clifford R, Scheltens P, Thompson PM (2010): The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67-77.
23. Frisoni GB, Jack CR (2011): Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use. Alzheimers Dement 7:171-174.
24. Gerardin E, Chételat G, Chupin M, Cuingnet R, Desgranges B, Kim H-S, Niethammer M, Dubois B, Lehéricy S, Garnero L, et al. (2009): Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage 47:1476-1486.
25. Hansen NL, Lauritzen M, Mortensen EL, Osler M, Avlund K, Fagerlund B, Rostrup E (2014): Subclinical cognitive decline in middle-age is associated with reduced task-induced deactivation of the brain's default mode network. Hum Brain Mapp 35:4488-4498.
26. Henneman WJP, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009): Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology 72:999-1007.
27. Igel C, Heidrich-Meisner V, Glasmachers T (2008): Shark. J Mach Learn Res 9:993-996.
28. Jack CRJ, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, et al. (2011a): Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 7:474-485 e4.
29. Jack J, Clifford R, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH (2011b): Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:257-262.
30. Jack J, Clifford R, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJL, Whitwell J, Ward C, et al. (2008): The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685-691.
31. Jack J, Clifford R, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010): Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128.
32. Jack J, Clifford R, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999): Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52:1397-1403.
33. Jack J, Clifford R, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, et al. (2005): Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65:1227-1231.
34. Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Nagren K, Kim BC, Tsui W, and others. (2008): Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging 35:2169-2181.
35. Lindeberg T. 2009. Scale Space. Encyclopedia of Computer Science and Engineering. John Wiley and Sons. p 2495-2504.
36. Liu Y, Teverovskiy L, Carmichael OT, Kikinis R, Shenton ME, Carter CS, Stenger VA, Davis SW, Aizenstein H, Becker JT, and others. (2004): Discriminative MR image feature analysis for automatic Schizophrenia and Alzheimer's disease classification. Miccai 3216:393-401.
37. Marques J, Genant HK, Lillholm M, Dam EB (2012): Diagnosis of osteoarthritis and prognosis of tibial cartilage loss by quantification of tibia trabecular bone from MRI. Magn Reson Med 42:735-742.
38. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR (2000): A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 55:1613-1620.
39. Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, Li Y, Boppana M, de Leon MJ (2005): Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64:1860-1867.
40. Nielsen M, Karemore G, Loog M, Raundahl J, Karssemeijer N, Otten JDM, Karsdal MA, Vachon CM, Christiansen C (2011): A novel and automatic mammographic texture resemblance marker is an independent risk factor for breast cancer. Cancer Epidemiol 35:381-387.
41. Nyúl LG, Udupa JK (1999): On standardizing the MR image intensity scale. Magn Reson Med 42:1072-1081.
42. Osler M, Avlund K, Mortensen EL (2013): Socio-economic position early in life, cognitive development and cognitive change from young adulthood to middle age. Eur J Public Health 23:974-980.
43. Osler M, Lund R, Kriegbaum M, Christensen U, Andersen AM (2006): Cohort profile: the Metropolit 1953 Danish male birth cohort. Int J Epidemiol 35:541-545.
44. Ramani A, Jensen JH, Helpern JA (2006): Quantitative MR imaging in Alzheimer disease. Radiology 241:26-44.
45. Sanfilipo MP, Benedict RHB, Zivadinov R, Bakshi R (2004): Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method. Neuroimage 22:1732-1743.
46. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, et al. (2009): Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65:403-413.
47. Sled JG, Zijdenbos AP, Evans AC (1998): A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87-97.
48. Sørensen L, Nielsen M, Lo P, Ashraf H, Pedersen JH, de Bruijne M (2012): Texture-based analysis of COPD: A data-driven approach. IEEE Trans Med Imaging 31:70-78.
49. Tanabe JL, Amend D, Schuff N, DiSclafani V, Ezekiel F, Norman D, Fein G, Weiner MW (1997): Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol 18:115-123.
50. Tuceryan M, Jain AK. 1998. Texture analysis. In: Chen CH, Pau LF, Wang PSP, editors. The Handbook of Pattern Recognition and Computer Vision (2nd Edition): World Scientific Publishing. p 207-248.
51. van Ginneken B, Katsuragawa S, ter Haar Romeny BM, Doi K, Viergever MA (2002): Automatic detection of abnormalities in chest radiographs using local texture analysis. IEEE Trans Med Imaging 21:139-149.
52. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR, Alzheimer's Disease Neuroimaging I (2009): MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 73:287-293.
53. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, J, Jennings RG, Karow D, Dale A, Alzheimer's Disease Neuroimaging I (2010): Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 31:347-354.
54. West MJ, Coleman PD, Flood DG, Troncoso JC (1994): Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772.
55. Wyman BT, Harvey DJ, Crawford K, Bernstein MA, Carmichael O, Cole PE, Crane PK, Decarli C, Fox NC, Gunter JL, et al. (2013): Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement 9:332-337.
56. Zhang J, Tong L, Wang L, Li N (2008): Texture analysis of multiple sclerosis: a comparative study. Magn Reson Imaging 26:1160-1166.
57. Zhang J, Yu C, Jiang G, Liu W, Tong L (2011): 3D texture analysis on MRI images of Alzheimer's disease. Brain Imaging Behav 6:61-69.